Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A

Our results suggest that DRB1*15:01 is the offending HLAII allele and that DR15 allotypes underlie the increased FEI risk in HAPs.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2025-04-09
DOI
https://doi.org/10.3389/fgene.2025.1506862
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A

Bernadette W. Luu, John Blangero, Jacob A. Galán, Marcio Almeida et al.
Frontiers in Genetics
Hemophilia Treatment and Research
article

Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A

Bernadette W. Luu, John Blangero, Jacob A. Galán, Marcio Almeida, Raja Rajalingam, Long V. Dinh, Juan M. Peralta, Marco H. Hofmann, Tom E. Howard, Eugene Maraskovsky, Henry Mead, Eli J. Fine, Eron G. Manusov, Miguel A. Escobar, Joanne E. Curran, Satish Kumar, Vincent P. Diego, Paul Lehmann, Sarah Williams‐Blangero, Jerry S. Powell, Harald H.H. Göring, Huy Huynh, Anne M. Verhagen
article en

Abstract

Our results suggest that DRB1*15:01 is the offending HLAII allele and that DR15 allotypes underlie the increased FEI risk in HAPs.

Frontiers in GeneticsVol. 16
University of California, San Francisco (US), The University of Texas Rio Grande Valley (US), Shaker Heights Public Library (US), Brownsville Public Library (US), Valley Baptist Medical Center (US), CSL (Australia) (AU), Indiana Hemophilia and Thrombosis Center (US), Case Western Reserve University (US), University of California, Davis (US), BioMarin (United States) (US)
Openalex Percentile: Top 91%
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.